Clinical Trials and Research

Sickle cell trait (SCT), long believed to be a benign carrier condition, is now being recognized for its association with various health complications. Despite its…

In parallel with the growth of ATHN's clinical studies, the number of new therapies for all blood disorders is increasing significantly. Some of the recently FDA-…